IN VITRO AND IN VIVO EVALUATION OF MUCOADHESIVE MICROSPHERES FOR TREATMENT OF HELICOBACTER PYLORI USING FACTORIAL DESIGN
The research involves characterization of in vitro and in vivo activity of mucoadhesive microspheres for Helicobacter pylori eradication. Amoxicillin and Famotidine were used as model drugs so that the dual therapy gives better H. pylori eradication. Preparation was carried by an emulsion-solvent evaporation method and 27 batches were prepared individually using 33 factorial designs to study the effect of independent variables on dependent variables. The in vitro mucoadhesion test and in vivo studies (Bacterial clearance study, in vivo mucoadhesion and in vivo ulcer index studies) were performed. A27 batch showed 66% mucoadhesion after 10 h and F24 showed 74% of mucoadhesion after 10 h. In the bacterial clearance studies, the mean bacterial count (log colony forming units) after oral administration of drug-loaded microspheres was found to be 3.72 Â± 0.58. The drug-loaded microspheres formulation exhibited better clearance from infection than plain drugs solution at the same doses. Drug microspheres formulation was found to be effective in the treatment of H. pylori infections effectively, and in in vivo mucoadhesion studies, the developed system was well taken up and processed by the cells of gastric mucosa of the stomach.
2. Jain SK, Gupta M, Sahoo AK, Pandey AN, Jain AK, Lectin conjugated gastro-retentive microspheres of amoxicillin for effective treatment of Helicobacter pylori, Curr Sci, 2014, 106, 267-276.
3. Brown LM, Helicobacter pylori: Epidemiology and routes of transmission, Epidemiol Rev, 2000, 22, 283-297.
4. Akiyama Y, Nagahara N, Nara E, Kitano M, Iwasa S, Yamamoto I, Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites, J Pharm Pharmacol, 1998, 50, 159-166.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).